AbbVie shares snap seven-session gaining streak
by
Contributor since / Followers
Contributor since / Followers
4 days ago
AbbVie (NYSE:ABBV) shares snapped seven straight sessions of gains, as the stock was down 0.9%
ABBV
Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus
by
Contributor since / Followers
Contributor since / Followers
1 week ago
Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark
No misses here: Healthcare earnings sweep past Wall Street estimates
by
Contributor since / Followers
Contributor since / Followers
1 week ago
All 16 S&P 500 healthcare companies that reported quarterly results this week, delivered an earnings
Abbvie raises 2025 EPS guidance to $12.09-$12.29 amid strong Skyrizi and Rinvoq growth
by
Contributor since / Followers
Contributor since / Followers
1 week ago
Earnings Call Insights: AbbVie Inc. (ABBV) Q1 2025 Management View CEO Rob Michael highlighted an
4 stocks to watch on Friday: GILD, ABBV, CL and SLB
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
hapabapa U.S. stock index futures on Friday were slightly lower, as Wall Street took a
AbbVie spikes as Q1 beat prompts guidance raise
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
vzphotos/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) shares traded higher in the premarket on Friday
AbbVie in charts: Revenues from Humira -50.6%, Skyrizi +70.6%, Rinvoq +57.2% Y/Y
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
More on AbbVie AbbVie: Thriving Beyond Humira’s Patent Cliff (Upgrade) AbbVie: Margin Expansion Potential Can
Earnings Snapshot: AbbVie tops Q1 estimates even as Humira sales lag, profit outlook beats
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
*Other Operating Data Consensus Source: Bloomberg More on AbbVie AbbVie: Thriving Beyond
AbbVie Non-GAAP EPS of $2.46 beats by $0.06, revenue of $13.34B beats by $420M
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
AbbVie press release (NYSE:ABBV): Q1 Non-GAAP EPS of $2.46 beats by $0.06. Revenue of $13.34B
AbbVie Q1 2025 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
vzphotos/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) is set to report its first-quarter 2025 earnings